XM does not provide services to residents of the United States of America.
N
N

Nasdaq


News

Rising above the noise, US stocks gain ground

LIVE MARKETS-Rising above the noise, US stocks gain ground Major U.S. stock indexes end higher, Dow out front Utilities lead S&P sector gainers; Comm Svcs weakest group Dollar, gold rise; crude up >2%; bitcoin nears $100k U.S. 10-Year Treasury yield edges up to ~4.42% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters.
A
G
N
N
S
U
U
B

Asia Morning Call-Global Markets

Asia Morning Call-Global Markets Nov 22 (Reuters) - Stock Markets Net Chng Stock Markets Net Chng S&P/ASX 200** 8323 -3.3 NZX 50** 12765.24 28.18 DJIA 43944.81 536.34 NIKKEI** 38026.17 -326.17 Nasdaq 18975.577 9.434 FTSE** 8149.27 64.2 S&P 500 5950.1 32.99 Hang Seng** 19601.11 -103.9 SPI 200 Fut 8425 78 STI** 3739.22 -4.42 SSEC** 3370.4039 2.4146 KOSPI** 2480.63 -1.66 ---------------------------------------------------------------------------------------- Bonds Bonds JP 10 YR Bond 1.095 0.03 KR
A
A
E
G
N
N
N
S
U
J
U
U
U

Iterum Therapeutics Regains Full Nasdaq Compliance

BRIEF-Iterum Therapeutics Regains Full Nasdaq Compliance Nov 21 (Reuters) - Iterum Therapeutics PLC ITRM.O : ITERUM THERAPEUTICS REGAINS FULL NASDAQ COMPLIANCE Source text: ID:nGNX51Ccw1 Further company coverage: ITRM.O
N

Mawson Infrastructure Group To Ring The Closing Bell At Nasdaq

BRIEF-Mawson Infrastructure Group To Ring The Closing Bell At Nasdaq Nov 21 (Reuters) - Mawson Infrastructure Group Inc MIGI.O : MAWSON INFRASTRUCTURE GROUP INC. TO RING THE CLOSING BELL AT NASDAQ Source text: ID:nGNX1QJPBr Further company coverage: MIGI.O
N

Super Micro Computer Nasdaq Non-Compliance Update

BRIEF-Super Micro Computer Nasdaq Non-Compliance Update Nov 20 (Reuters) - Nasdaq Inc NDAQ.O : SUPER MICRO COMPUTER INC. NASDAQ NON-COMPLIANCE UPDATE SUPER MICRO COMPUTER: RECEIVED LETTER FROM NASDAQ THAT CO IS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE 5250(C)(1) Source text: ID:nBwqSYMqa Further company coverage: NDAQ.O
N

Scworx Announces Compliance With Nasdaq’S Periodic Reporting Listing Standard

BRIEF-Scworx Announces Compliance With Nasdaq’S Periodic Reporting Listing Standard Nov 20 (Reuters) - Nasdaq Inc NDAQ.O : SCWORX ANNOUNCES COMPLIANCE WITH NASDAQ’S PERIODIC REPORTING LISTING STANDARD Source text: ID:nGNX9Rzmgn Further company coverage: NDAQ.O
N

Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule

BRIEF-Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule Nov 20 (Reuters) - Adverum Biotechnologies Inc ADVM.O : ADVERUM BIOTECHNOLOGIES REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNX8yKzqC Further company coverage: ADVM.O
N

Color Star Technology Received Nasdaq Notification Letter Regarding Bid Price Deficiency

BRIEF-Color Star Technology Received Nasdaq Notification Letter Regarding Bid Price Deficiency Nov 20 (Reuters) - Color Star Technology Co Ltd ADD.O : COLOR STAR TECHNOLOGY RECEIVED NASDAQ NOTIFICATION LETTER REGARDING BID PRICE DEFICIENCY Source text: ID:nGNX1MVr5r Further company coverage: ADD.O
N

D. Boral Capital Acted As Sole Bookrunner For Nature's Miracle Holding In Connection With Its $3 Million Public Offering

BRIEF-D. Boral Capital Acted As Sole Bookrunner For Nature's Miracle Holding In Connection With Its $3 Million Public Offering Nov 20 (Reuters) - Nasdaq Inc NDAQ.O : D. BORAL CAPITAL ACTED AS SOLE BOOKRUNNER FOR NATURE'S MIRACLE HOLDING INC. (NASDAQ: NMHI) IN CONNECTION WITH ITS $3.0 MILLION PUBLIC OFFERING Source text: ID:nGNX9DQ9HJ Further compan
N

QuidelOrtho drops as Carlyle exits

BUZZ-QuidelOrtho drops as Carlyle exits ** QuidelOrtho Corp's QDEL.O shares down 6.6% premarket to $36.05 after Carlyle Group CG.O offloads remaining 12% stake ** San Diego-based medical diagnostics co late Tues announced pricing ~8.3 mln share secondary offering by the private equity firm ** QDEL has ~67.3 mln shares outstanding for ~$2.6 bln market cap ** Goldman Sachs sole underwriter for offering ** Last week, activist investor Jana Partners disclosed it sold its remaining 1-mln-share stake
G
N

Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing

BRIEF-Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing Nov 20 (Reuters) - Nasdaq Inc NDAQ.O : PSYENCE BIOMEDICAL ANNOUNCES FAVORABLE RESULT OF NASDAQ LISTING QUALIFICATIONS HEARING PSYENCE BIOMEDICAL LTD - NASDAQ GRANTS PSYENCE BIOMED EXTENSION UNTIL DECEMBER 31, 2024 Source text: ID:nGNX6M6hX0 Further company
N

Sol-Gel Announces 180-Day Extension To Regain Compliance With Nasdaq Minimum Bid Requirement

BRIEF-Sol-Gel Announces 180-Day Extension To Regain Compliance With Nasdaq Minimum Bid Requirement Nov 20 (Reuters) - Sol-Gel Technologies SLGL.BLUE : SOL-GEL ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID REQUIREMENT Source text: ID:nGNX4X6b6f Further company coverage: SLGL.BLUE
N

QuidelOrtho falls as Carlyle to offload remaining stake

BUZZ-QuidelOrtho falls as Carlyle to offload remaining stake ** Shares of QuidelOrtho Corp QDEL.O down 6.4% at $36.10 in extended trading as Carlyle Group CG.O to divest its remaining ~12% stake ** Medical diagnostics firm launches ~8.3 mln share secondary offering by the private equity giant ** QDEL has ~67.3 mln shares outstanding for $2.6 bln market cap ** Goldman Sachs sole underwriter for offering ** QDEL shares on Tues closed up 3.2% at $38.58 ** YTD, stock has lost ~48% vs Nasdaq's .IXIC
G
N

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BRIEF-Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Nov 19 (Reuters) - Nasdaq Inc NDAQ.O : SCHRÖDINGER REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nBw5xW8K7a Further company coverage: NDAQ.O
N

Akari Therapeutics Regains Full Nasdaq Compliance

BRIEF-Akari Therapeutics Regains Full Nasdaq Compliance Nov 19 (Reuters) - Akari Therapeutics PLC AKTX.O : AKARI THERAPEUTICS REGAINS FULL NASDAQ COMPLIANCE AKARI THERAPEUTICS PLC - NASDAQ HEARING FOR AKARI THERAPEUTICS ON NOVEMBER 21 CANCELLED Source text: ID:nGNX109G1z Further company coverage: AKTX.O
N

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BRIEF-Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Nov 19 (Reuters) - Nasdaq Inc NDAQ.O : VAXART, INC. REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNXcbBNTH Further company coverage: NDAQ.O
N

Tenaya Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BRIEF-Tenaya Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Nov 19 (Reuters) - Nasdaq Inc NDAQ.O : TENAYA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) Source text: ID:nGNX4PVLGh Further company coverage: NDAQ.O
N

Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market

BRIEF-Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market Nov 19 (Reuters) - Achilles Therapeutics PLC 698y.F : ACHILLES THERAPEUTICS RECEIVES APPROVAL TO TRANSFER TO NASDAQ CAPITAL MARKET ACHILLES THERAPEUTICS PLC - TRANSFER EFFECTIVE NOVEMBER 19, 2024 Source text: ID:nGNX9BFw7R Further company coverage: [698y.F]
N

J-Long Group Limited Announces Receipt of NASDAQ Determination Letter

BRIEF-J-Long Group Limited Announces Receipt of NASDAQ Determination Letter Nov 19 (Reuters) - J-Long Group Ltd JL.O : J-LONG GROUP LIMITED ANNOUNCES RECEIPT OF NASDAQ DETERMINATION LETTER J-LONG GROUP LTD - BID PRICE BELOW $1 FOR 30 CONSECUTIVE DAYS J-LONG GROUP LTD - SHARES TO BE SUSPENDED ON NOVEMBER 25, 2024 Source text: ID:nGNX6S9mMJ Further c
N

Super Micro Appoints BDO USA As Auditor And Filing Of Compliance Plan With Nasdaq

BRIEF-Super Micro Appoints BDO USA As Auditor And Filing Of Compliance Plan With Nasdaq Nov 18 (Reuters) - SUPER MICRO COMPUTER SMCI.O : SUPERMICRO ANNOUNCES APPOINTMENT OF BDO USA AS INDEPENDENT AUDITOR AND FILING OF COMPLIANCE PLAN WITH NASDAQ SUPER MICRO COMPUTER INC - PURSUANT TO NASDAQ RULES, SUPERMICRO'S SECURITIES WILL REMAIN LISTED PENDING NASDAQ'S REVIEW OF COMPLIANCE PLAN.
N



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.